STOCK TITAN

Glucose Health (GLUC) Stock News

GLUC OTC

Welcome to our dedicated page for Glucose Health news (Ticker: GLUC), a resource for investors and traders seeking the latest updates and insights on Glucose Health stock.

Glucose Health, Inc. reports company developments tied to its consumer-health business in soluble-fiber nutrition products for healthy glucose metabolism and metabolic wellness. News commonly covers the GLUCODOWN® and FIBER UP® brands, retail distribution through pharmacy chains and online channels, national advertising activity, and product positioning around dietary fiber and metabolic support.

Company updates also address governance and capital-structure actions, including board and management appointments, preferred stock conversions, debt settlement activity, and financing priorities related to growth in retail distribution and brand development.

Rhea-AI Summary

Glucose Health (OTC: GLUC) announced the resignation of its Chief Executive Officer and Chief Financial Officer, effective September 30, 2025. The departure was voluntary and not requested by the company. Murray Fleming, the company's sole Director, will temporarily assume both roles to maintain administrative continuity and assist in identifying new officers.

Notably, the company disclosed having limited operating capital and expressed uncertainty about its ability to continue as a going concern. The interim leadership arrangement will continue until permanent successors are appointed, the company ceases operations, or the Board takes alternative action regarding officer appointments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.34%
Tags
none
-
Rhea-AI Summary

Glucose Health, Inc. (OTC: GLUC) has launched a strategic media campaign across CNBC, Fox Business, and Bloomberg Television to highlight the U.S. Department of Health and Human Services' designation of dietary fiber as a "nutrient of public health concern." The campaign targets the New York City metro area to attract retail, institutional, and investment bank attention.

The company's two main brands, GlucoDown® and Fiber Up®, feature patent-pending soluble fiber formulations competing with established products like Glucerna® and Metamucil®. GlucoDown® supports balanced glucose levels, while Fiber Up® targets metabolic and digestive health. The company aims to capitalize on expected increased consumer demand following the federal designation of dietary fiber as a priority nutrient in the Dietary Guidelines for Americans, 2020-2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.5%
Tags
none
-
Rhea-AI Summary

Glucose Health, Inc. (OTC: GLUC) has highlighted its long-standing commitment to using only natural colors in its GlucoDown® and Fiber Up® products, contrasting with competitors like Metamucil® who have traditionally used synthetic dyes. Since 2017, the company's products have been formulated with natural colors from vegetables like beets and carrots, avoiding artificial dyes such as Yellow 6 and Red 40.

The company emphasizes its patent-pending metabolic nutrition formulation that supports metabolic wellness, including balanced glucose and cholesterol levels. Their products contain 100% soluble dietary fiber and natural flavors, with no preservatives or fillers, positioning the company advantageously as the U.S. Department of Health and Human Services has designated dietary fiber as a nutrient of public health concern.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.1%
Tags
none
Rhea-AI Summary

Glucose Health, Inc. (OTC: GLUC) highlighted the U.S. Department of Health and Human Services (HHS) and USDA's designation of dietary fiber as one of four nutrients of public health concern in their 2020-2025 Dietary Guidelines for Americans. This federal recognition validates the company's strategic focus on fiber-based nutrition products.

The company's flagship brand GlucoDown®, a dietary fiber-infused drink formulated for balanced glucose levels, competes with major brands like Glucerna® and Boost® in national pharmacy chains. Additionally, their Fiber Up® brand, utilizing a variant of their patent-pending formulation, targets digestive and gut health, competing with Metamucil®.

CEO Murray Fleming emphasized that this federal designation aligns with their core mission since 2017, positioning the company to potentially benefit from increased government funding for dietary fiber awareness campaigns and anticipated rising consumer demand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.65%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.68%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32%
Tags
none
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.28%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.67%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.52%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.53%
Tags
none

FAQ

What is the current stock price of Glucose Health (GLUC)?

The current stock price of Glucose Health (GLUC) is $0.4643 as of June 22, 2026.

What is the market cap of Glucose Health (GLUC)?

The market cap of Glucose Health (GLUC) is approximately 11.8M.